Karyopharm Therapeutics (KPTI) EBT Margin Growth (3y) (2015 - 2026)
Karyopharm Therapeutics (KPTI) EBT Margin Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -484.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 132.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 6,685.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -2,054.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8,006.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 9,980.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -9,922.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 31,363.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -5,319.00 |
| 10 | Karyopharm Therapeutics | 56.72 Mn | 56.72 Mn | 32.35 Mn | -11,398.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11,398.00 |
| Dec 31, 2025 | 38,155.00 |
| Sep 30, 2025 | 2,523.00 |
| Jun 30, 2025 | 2,523.00 |
| Mar 31, 2025 | 852.00 |
| Dec 31, 2024 | 11,859.00 |
| Sep 30, 2024 | 5,457.00 |
| Jun 30, 2024 | 29,225.00 |
| Mar 31, 2024 | 13,362.00 |
| Dec 31, 2023 | -2,889.00 |
| Sep 30, 2023 | 15,476.00 |
| Jun 30, 2023 | 5,163.00 |
| Mar 31, 2023 | 20,341.00 |
| Dec 31, 2022 | 15,171.00 |
| Sep 30, 2022 | 21,408.00 |
| Jun 30, 2022 | 33,391.00 |
| Mar 31, 2022 | 4.26 Mn |
| Dec 31, 2021 | 2.83 Mn |
| Sep 30, 2021 | 2.00 Mn |
| Jun 30, 2021 | -6,720.00 |